Search research articles
Contact Us
Filters
Showing results (51-60 of 98) with videos related to
Page
of 10
Sort By:
JCO Precision Oncology
|
November 4, 2022
A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab
Stefanie Fischer, Thorsten O Götze, Aurelius Omlin, et al.
Journal of Translational Medicine
|
January 9, 2013
T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein
Julien Laurent, Cedric Touvrey, Silke Gillessen, et al.
Investigational New Drugs
|
April 29, 2014
Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study
Yohann Loriot, Karim Fizazi, Robert J Jones, et al.
Clinical Genitourinary Cancer
|
October 29, 2017
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
Daniel Heinrich, Jasmin Bektic, Andries M Bergman, et al.
Praxis
|
September 20, 2018
[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]
Aurelius Omlin, Martin Spahn, Jörg Beyer, et al.
European Urology Open Science
|
May 15, 2023
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment
Dominik Menges, Michela C Piatti, Aurelius Omlin, et al.
European Urology Focus
|
July 30, 2017
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey
David Lorente, Praful Ravi, Niven Mehra, et al.
Science Translational Medicine
|
September 19, 2014
Tumor clone dynamics in lethal prostate cancer
Suzanne Carreira, Alessandro Romanel, Jane Goodall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2023
Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
Aurelius Omlin, Richard Cathomas, Gunhild von Amsberg, et al.
Swiss Medical Weekly
|
September 8, 2021
Swiss germ-cell cancer consensus recommendations
Jörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 98) with videos related to
Sort By:
Page
of 10
JCO Precision Oncology
|
November 4, 2022
A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab
Stefanie Fischer, Thorsten O Götze, Aurelius Omlin, et al.
Journal of Translational Medicine
|
January 9, 2013
T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein
Julien Laurent, Cedric Touvrey, Silke Gillessen, et al.
Investigational New Drugs
|
April 29, 2014
Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study
Yohann Loriot, Karim Fizazi, Robert J Jones, et al.
Clinical Genitourinary Cancer
|
October 29, 2017
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
Daniel Heinrich, Jasmin Bektic, Andries M Bergman, et al.
Praxis
|
September 20, 2018
[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation]
Aurelius Omlin, Martin Spahn, Jörg Beyer, et al.
European Urology Open Science
|
May 15, 2023
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment
Dominik Menges, Michela C Piatti, Aurelius Omlin, et al.
European Urology Focus
|
July 30, 2017
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey
David Lorente, Praful Ravi, Niven Mehra, et al.
Science Translational Medicine
|
September 19, 2014
Tumor clone dynamics in lethal prostate cancer
Suzanne Carreira, Alessandro Romanel, Jane Goodall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2023
Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
Aurelius Omlin, Richard Cathomas, Gunhild von Amsberg, et al.
Swiss Medical Weekly
|
September 8, 2021
Swiss germ-cell cancer consensus recommendations
Jörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
Page
of 10